Zevra Therapeutics, Inc. (ZVRA)

Zevra Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 20, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	453	272	158	308	48	13
Market Cap Growth	123.24%	71.57%	-48.52%	536.60%	283.47%	-73.24%
Enterprise Value	424	233	97	178	112	86
Last Close Price	8.49	6.55	4.59	8.71	11.20	6.07
Forward PE	-	-	-	-	2.95	-
PS Ratio	14.76	9.90	15.59	10.74	3.64	0.98
PB Ratio	6.48	4.39	2.11	2.42	-0.73	-0.17
P/TBV Ratio	-	-	2.11	2.42	-	-
P/FCF Ratio	-	-	-	29.76	-	-
P/OCF Ratio	-	-	-	29.47	-	-
EV/Sales Ratio	17.30	8.49	9.52	6.21	8.43	6.71
EV/EBITDA Ratio	-	-	-	22.27	-	-
EV/EBIT Ratio	-	-	-	23.01	-	-
EV/FCF Ratio	-	-	-	17.20	-	-
Debt / Equity Ratio	0.86	0.71	0.19	0.01	-1.06	-1.07
Debt / EBITDA Ratio	-	-	-	0.18	-	-
Debt / FCF Ratio	-	-	-	0.16	-	-
Asset Turnover	0.15	0.19	0.08	0.40	1.22	0.69
Quick Ratio	2.82	1.15	7.58	26.92	0.90	0.94
Current Ratio	2.88	1.18	7.72	27.20	1.11	1.28
Return on Equity (ROE)	-130.67%	-67.23%	-26.48%	-28.18%	-	-
Return on Assets (ROA)	-32.80%	-21.55%	-12.54%	6.70%	-27.52%	-68.24%
Return on Capital (ROIC)	-44.81%	-31.82%	-14.28%	7.27%	-62.18%	-121.30%
Earnings Yield	-19.79%	-16.95%	-16.90%	-2.78%	-26.40%	-194.59%
FCF Yield	-15.37%	-12.45%	-11.88%	3.36%	-4.08%	-188.57%
Buyback Yield / Dilution	-23.73%	-2.79%	-15.87%	-647.71%	-114.79%	-65.39%
Total Shareholder Return	-23.73%	-2.79%	-15.87%	-647.71%	-114.79%	-65.39%

Source: S&P Capital IQ. Standard template. Financial Sources.